Who
venBio Global Strategic Fund IV, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Attovia Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $13.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Aug 2026
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,311,870 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —821,998 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —665,147 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —21,477,273 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —7,636,362 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —6,179,219 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Bought | $6.5M382,352 at $17.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —21,477,273 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —7,636,362 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —6,179,219 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,311,870 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —821,998 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —665,147 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Bought | $6.5M382,352 at $17.00 | filing |
News
No headline names them, or the companies they trade most, lately.